TOLVAPTAN BIOGARAN 30 mg, tablet + tolvaptan biogaran 60 mg, tablet 28 tablets
Active ingredients: Tolvaptan
Commercialized according to BDPMDispensing in France: Prescription only
Tablet28 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TOLVAPTAN BIOGARAN 30 mg, comprimé + TOLVAPTAN BIOGARAN 60 mg, comprimé
- Pharmaceutical form
- comprimé et comprimé
- Route of administration
- orale
- Presentation description
- 4 plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 7 comprimé(s) - 4 plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 7 comprimé(s)
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a hospital doctor
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66055638CIP73027775CIP133400930277751Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TOLVAPTANcomprimé de 30 mg | 30 mg · un comprimé | SA |
| TOLVAPTANcomprimé de 60 mg | 60 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.